ALPMY - Astellas Pharma's (ALPMF) Management on Q3 2021 Results - Earnings Call Transcript

Astellas Pharma Inc (ALPMF) Q3 2021 Earnings Conference Call January 29, 2021 2:00 AM ET Company Participants Naoki Okamura – Corporate Executive Vice President, Chief Strategy Officer and Chief Financial Officer Yukio Matsui – Chief Commercial Officer Mike Kitagawa – Development Project Management Head Conference Call Participants Hidemaru Yamaguchi – Citigroup Securities Kazuaki Hashiguchi – Daiwa Securities Fumiyoshi Sakai – Crédit Suisse AG Motoya Kohtani – Nomura Securities Yoshitsugu Shitaka – Astellas Pharma Inc Madoka Sato – Shroders Shinichiro Muraoka – Morgan Stanley MUFG Securities Presentation Naoki Okamura Once again, hello, everyone. Okamura speaking. Thank you very much for participating in the meeting by Astellas on the FY 2020 third quarter financial results. We’d like to use the slides you have at hand to talk about the results and also the initiatives for sustainable growth. Please turn to Page 2. This is a cautionary statement regarding forward-looking information. Fuji already

For further details see:

Astellas Pharma's (ALPMF) Management on Q3 2021 Results - Earnings Call Transcript